Roche's oseltamivir [`Tamiflu'] and Glaxo Wellcome's zanamivir [`Relenza'] are `neck and neck'

Roche's oseltamivir [`Tamiflu'] and Glaxo Wellcome's zanamivir [`Relenza'] are `neck and neck'. Pharmacoecon. Outcomes News 246, 12 (2000). https://doi.org/10.1007/BF03266799

Download citation

Published: 07 February 2013
Issue Date: January 2000
DOI: https://doi.org/10.1007/BF03266799

Keywords

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Roche's oseltamivir [`Tamiflu'] and Glaxo Wellcome's zanamivir [`Relenza'] are `neck and neck'

Access this article

Rights and permissions

About this article

Cite this article

Share this article

Keywords

Search

Navigation